XML 86 R63.htm IDEA: XBRL DOCUMENT v3.21.1
Geographic and Segment Information - Segment Info (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
USD ($)
segment
geographic_region
Mar. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
Segment Reporting Information [Line Items]      
Reportable segments | segment 2    
Number of geographic regions in which entity operates | geographic_region 3    
Net sales $ 247,603 $ 242,397  
Restructuring expenses 6,092 1,580  
Amortization of intangibles 6,699 10,267  
Operating (loss) income from continuing operations (4,423) 608  
Interest income (74) 148  
Interest expense (15,936) (4,849)  
Foreign exchange and other losses (6,369) (1,914)  
Loss from continuing operations before tax (26,802) (6,007)  
Assets 2,369,169   $ 2,411,351
Operating Segments | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 143,166 152,069  
Restructuring expenses 1,896 686  
Operating Segments | Neuromodulation      
Segment Reporting Information [Line Items]      
Net sales 103,699 89,657  
Restructuring expenses 1,210 503  
Other      
Segment Reporting Information [Line Items]      
Net sales 738 671  
Restructuring expenses 2,986 391  
Continuing Operations      
Segment Reporting Information [Line Items]      
Total reportable segment income from continuing operations 8,998 15,929  
Merger and integration expenses 630 3,474  
Restructuring expenses 6,092 1,580  
Amortization of intangibles 6,699 10,267  
Operating (loss) income from continuing operations (4,423) 608  
Capital expenditures 5,114 12,374  
Continuing Operations | Operating Segments | Cardiovascular      
Segment Reporting Information [Line Items]      
Total reportable segment income from continuing operations 5,628 8,681  
Assets 1,319,493   1,361,669
Capital expenditures 4,149 5,292  
Continuing Operations | Operating Segments | Neuromodulation      
Segment Reporting Information [Line Items]      
Total reportable segment income from continuing operations 34,039 33,858  
Assets 642,123   673,586
Capital expenditures 40 5,239  
Continuing Operations | Other      
Segment Reporting Information [Line Items]      
Total reportable segment income from continuing operations (30,669) (26,610)  
Assets 407,553   $ 376,096
Capital expenditures 925 1,843  
United States      
Segment Reporting Information [Line Items]      
Net sales 133,336 123,583  
United States | Operating Segments | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 51,036 50,307  
United States | Operating Segments | Neuromodulation      
Segment Reporting Information [Line Items]      
Net sales 82,300 73,276  
Europe      
Segment Reporting Information [Line Items]      
Net sales 50,817 54,716  
Europe | Operating Segments | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 39,138 44,133  
Europe | Operating Segments | Neuromodulation      
Segment Reporting Information [Line Items]      
Net sales 11,679 10,583  
Rest of World      
Segment Reporting Information [Line Items]      
Net sales 63,450 64,098  
Rest of World | Operating Segments | Cardiovascular      
Segment Reporting Information [Line Items]      
Net sales 52,992 57,629  
Rest of World | Operating Segments | Neuromodulation      
Segment Reporting Information [Line Items]      
Net sales 9,720 5,798  
Cardiopulmonary      
Segment Reporting Information [Line Items]      
Net sales 108,719 116,367  
Cardiopulmonary | United States      
Segment Reporting Information [Line Items]      
Net sales 35,759 36,858  
Cardiopulmonary | Europe      
Segment Reporting Information [Line Items]      
Net sales 30,626 34,234  
Cardiopulmonary | Rest of World      
Segment Reporting Information [Line Items]      
Net sales 42,334 45,275  
Heart Valves      
Segment Reporting Information [Line Items]      
Net sales 21,455 25,211  
Heart Valves | United States      
Segment Reporting Information [Line Items]      
Net sales 2,717 3,373  
Heart Valves | Europe      
Segment Reporting Information [Line Items]      
Net sales 8,284 9,529  
Heart Valves | Rest of World      
Segment Reporting Information [Line Items]      
Net sales 10,454 12,309  
Advanced Circulatory Support      
Segment Reporting Information [Line Items]      
Net sales 12,992 10,491  
Advanced Circulatory Support | United States      
Segment Reporting Information [Line Items]      
Net sales 12,560 10,076  
Advanced Circulatory Support | Europe      
Segment Reporting Information [Line Items]      
Net sales 228 370  
Advanced Circulatory Support | Rest of World      
Segment Reporting Information [Line Items]      
Net sales $ 204 $ 45